Austrian Pharmaceuticals & Biotech Potentially Undervalued Companies

Regeneron Pharmaceuticals

Market Cap: €59.8b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Pfizer

Market Cap: €137.0b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Merck

Market Cap: €199.0b

Operates as a healthcare company worldwide.

IQVIA Holdings

Market Cap: €30.8b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

SCHOTT Pharma KGaA

Market Cap: €3.2b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

Sanofi

Market Cap: €94.3b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Teva Pharmaceutical Industries

Market Cap: €22.1b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Cosmo Pharmaceuticals

Market Cap: €1.0b

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Bayer

Market Cap: €26.8b

Operates as a life science company worldwide.

Dermapharm Holding

Market Cap: €1.7b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

Merck KGaA

Market Cap: €46.2b

Operates as a science and technology company in Germany.

BioMarin Pharmaceutical

Market Cap: €10.3b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

H. Lundbeck

Market Cap: €43.1b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Viatris

Market Cap: €11.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Marinomed Biotech

Market Cap: €36.4m

A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.

H. Lundbeck

Market Cap: €43.1b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Bristol-Myers Squibb

Market Cap: €89.9b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Novartis

Market Cap: €189.7b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Biogen

Market Cap: €20.2b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Evotec

Market Cap: €1.1b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Johnson & Johnson

Market Cap: €425.5b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Valneva

Market Cap: €741.9m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Eurofins Scientific

Market Cap: €10.8b

Provides various analytical testing and laboratory services worldwide.

Zoetis

Market Cap: €62.8b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Gerresheimer

Market Cap: €1.2b

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Bavarian Nordic

Market Cap: €17.9b

Develops, manufactures, and supplies life-saving vaccines.

CureVac

Market Cap: €1.2b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Thermo Fisher Scientific

Market Cap: €176.7b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

argenx

Market Cap: €36.9b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Genmab

Market Cap: €114.0b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Novo Nordisk

Market Cap: €1.6t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Avantor

Market Cap: €8.2b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Qiagen

Market Cap: €9.8b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.9b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Pharma Mar

Market Cap: €1.5b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Sartorius Stedim Biotech

Market Cap: €17.0b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.